Use of rivaroxaban in sickle cell disease and venous thromboembolism: A case report

INTRODUCTION: Sickle cell disease (SCD) is a hematological disorder characterized by sickling of red blood cells. Patients are at increased risk of venous thromboembolism. There are no guidelines for the management of venous thromboembolism in sickle cell disease specifically in terms of the anticoa...

Descripción completa

Detalles Bibliográficos
Autores principales: Rozi, Waail, Ali, Elrazi Awadelkarim Hamid, Al-Mashdali, Abdulrahman F., Abdelrazek, Mohamed, Yassin, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702265/
https://www.ncbi.nlm.nih.gov/pubmed/34941038
http://dx.doi.org/10.1097/MD.0000000000027988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702265/
https://www.ncbi.nlm.nih.gov/pubmed/34941038
http://dx.doi.org/10.1097/MD.0000000000027988

Ejemplares similares